Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 427

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 427
---
 stock of DiamiR, a private company incorporated in Delaware, United States, from DiamiR’s shareholders through the issuance of shares of the Company’s common stock with an estimated fair value of $32.8million (the “Acquisition”). The Company considers completion of the merger agreement to be probable. The accompanying unaudited pro forma condensed combined statement of financial position as at June 30, 2025 gives effect to the Acquisition as if it had been consummated on June 30, 2025; and the accompanying unaudited pro forma condensed combined statements of operations for the year ended December 31, 2024 and the six months ended June30, 2025 gives effect to the Acquisition as if it had been consummated on January 1, 2024. The following unaudited pro forma condensed combined balance sheet as of June 30, 2025, combines the historical consolidated balance sheet of Aptorum as of June 30, 2025 with the historical balance sheet of DiamiR as of May 31, 2025 giving further effect to the pro forma adjustments described in Note (i) to the “ Notes To The Unaudited Pro Forma Consolidated Combined Financial Information”included in this proxy statement/prospectus, as if they had been consummated as of June30, 2025. The following unaudited pro forma consolidated combined statements of operations for the year ended December 31, 2024 combine the historical consolidated statement of operations of Aptorum for the year ended December 31, 2024 and the historical statements of operations of DiamiR for the twelve months ended February 28, 2025 (consisting of the first nine months of its fiscal year ending May 31, 2025 and the last three months of its fiscal year ended May 31, 2024), giving effect to the pro forma adjustments described in Note (i) to the “ Notes To The Unaudited Pro Forma Consolidated Combined Financial Information” included in this proxy statement/prospectus, as if they had been consummated on January 1, 2024, the beginning of the earliest period presented. The unaudited pro forma consolidated combined statements of operations for the six months ended June30, 2025 combine the historical consolidated statement of operations of Aptorum for the six months ended June30, 2025 and the historical statements of operations of DiamiR for the six months ended May31, 2025.